rfhg_160668.1

Basic information about the TSS

---

TSS ID: rfhg_160668.1 TSS ID(Version3): hg_137330.1 Species: human Chr: chr13		Start: 49792510 End: 49792598 Strand: -
Source datasets	FANTOM5|DRA000914|PRJNA401781|PRJNA548673|PRJDB5282 |PRJNA4843412|DRA013844|PRJNA615891
Protocol	CAGE|ReCappable-seq|C1CAGE|NETCAGE|SLIC_CAGE
TSS cluster detected*	9

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC017355:0 BC024202:0 D89618:0 AK291000:0 AK290528:0 Y12394:0 AF005263:0 AK223480:0 GeneID: 3839 HGNC/MGI_ID: HGNC:6396 UniProt_ID: Q53F09 Nearer transcript ids and distances: AB528414:1 AF034756:2 DQ892644:2 DQ895882:2 KJ897108:3 ENST00000261667.8:-84 NM_002267.4:-84 BC035090:-323 view more...

Gene_name: karyopherin subunit alpha 3 Gene_symbol: KPNA3 Gene_synonyms: IPOA4 SRP1gamma SRP4 hSRP1 Gene_source: HGNC:6396

TATA-Box annotation

---

Distance to TSS:	128
Nearest PromoterID:	NM_002267
Entrez ID:	3839
Nearest Unigene:	Hs.527919
Nearest Refseq:	NM_002267
Nearest Ensembl:	ENSG00000102753
Gene Name:	karyopherin subunit alpha 3
Gene Alias:	IPOA4|SRP1|SRP1gamma|SRP4|hSRP1
Gene Type:	protein-coding
CpG%:	0.170455
GC%:	0.797753
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KPNA3 p2@KPNA3 p3@KPNA3 p4@KPNA3 p7@KPNA3
Sample		p1@KPNA3	p2@KPNA3	p3@KPNA3	p4@KPNA3	p7@KPNA3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	20.26	4.87	2.92	0.78	3.12
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.05	4.65	2.23	0.40	3.24
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	23.34	3.47	3.09	0.39	4.82
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.63	2.91	3.95	0.42	3.95
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	17.55	3.15	2.25	0.22	4.72
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.09	3.68	2.13	0.39	2.91
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.43	5.01	3.27	0.65	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	29.55	4.36	1.21	0.48	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.21	3.85	1.92	0.21	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	3.48	2.32	0.00	5.22
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	15.77	3.64	1.21	1.21	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	3.66	2.44	0.00	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.48	1.29	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.47	1.20	0.30	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.88	1.76	0.88	1.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	7.54	1.01	0.75	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.99	1.09	0.44	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	1.27	0.00	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	3.73	1.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.22	0.75	0.75	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.42	1.07	0.67	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.77	1.90	0.69	0.52	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.47	1.29	0.65	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.25	2.18	0.73	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	5.16	2.58	0.77	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.33	0.95	0.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	8.24	1.65	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	2.83	1.89	1.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.59	1.29	0.97	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.95	1.99	0.72	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	8.37	2.51	0.63	1.26	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.38	0.98	0.20	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.86	0.63	1.27	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.70	2.31	1.32	1.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.03	1.87	0.75	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.16	1.92	1.15	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	6.95	3.07	1.02	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	1.81	0.40	1.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	10.80	2.70	1.89	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	10.32	2.88	1.44	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	11.76	2.82	0.71	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.95	1.61	1.61	1.32	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	7.38	2.32	1.05	1.48	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.74	2.97	1.75	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	10.44	2.01	1.41	1.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.24	2.09	0.93	1.40	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.20	2.88	1.44	2.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	8.35	2.09	1.49	1.19	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.94	3.11	1.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.89	3.24	0.81	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.79	3.07	1.43	1.23	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.23	3.78	2.00	1.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.39	1.42	1.77	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.96	3.65	0.66	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.13	5.87	2.52	3.36	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	1.84	3.21	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.48	3.89	1.30	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.46	3.21	0.32	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	9.74	1.89	1.89	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	2.82	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	4.49	1.12	0.00	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	2.39	2.39	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	5.10	1.36	0.34	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.87	3.57	0.32	2.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	2.84	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	7.90	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.85	0.98	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	0.50	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	9.27	2.98	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.42	0.93	0.62	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.50	2.14	0.31	1.83	0.00
Adipocyte - breast, donor1	11376-118A8	25.82	4.43	3.01	2.06	0.79
Adipocyte - breast, donor2	11327-117E4	18.77	4.49	2.89	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	29.26	6.74	6.49	2.16	0.25
Adipocyte - omental, donor2	11474-119C7	14.20	3.74	4.48	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	1.00	1.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	17.86	1.28	1.91	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	1.10	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	4.06	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	8.86	2.61	1.22	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	22.49	1.37	0.59	1.37	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	14.41	2.57	3.09	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	16.45	0.84	1.12	3.62	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	13.52	4.70	1.18	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	27.03	4.42	1.77	0.80	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	20.66	5.16	2.58	0.97	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	2.13	4.27	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	28.38	3.90	4.45	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	14.56	2.50	3.33	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	3.01	2.26	0.25	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	11.78	1.96	1.64	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	17.05	3.04	1.83	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	13.04	2.43	1.33	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	0.36	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.03	1.26	0.54	1.26	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.51	1.85	1.23	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	19.45	2.40	0.92	1.49	0.00
Anulus Pulposus Cell, donor2	11463-119B5	11.76	0.49	1.96	1.47	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.44	1.80	3.15	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.33	1.74	5.21	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	13.15	0.30	1.79	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	1.26	2.53	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.92	2.64	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	0.32	1.62	1.62	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.02	2.43	2.91	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	11.28	2.38	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.79	0.75	4.14	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	1.45	2.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	2.51	3.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	25.70	2.14	2.97	1.65	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	1.36	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.53	0.60	1.36	1.06	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.39	1.07	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	15.49	3.40	1.70	0.94	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.51	2.94	2.14	1.07	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	15.59	1.49	1.33	1.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	16.12	1.37	1.37	1.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.16	1.94	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	13.28	2.66	1.14	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	12.54	0.57	2.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	17.32	1.71	1.92	0.86	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.49	1.55	2.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	2.82	2.82	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	15.43	1.93	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	18.55	1.43	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	0.58	3.51	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.05	1.51	0.90	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	2.03	1.53	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	2.29	2.55	1.78	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	1.27	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	11.22	0.00	1.73	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.61	1.48	1.91	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.21	2.03	0.87	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	17.01	0.94	3.78	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.97	2.03	1.86	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.15	1.07	2.14	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	3.01	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	0.73	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.63	3.68	2.07	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.00	1.27	1.53	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	15.69	2.48	1.24	1.03	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.55	2.75	0.61	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	1.43	2.39	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.63	1.55	1.55	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	0.00	1.53	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	0.55	3.32	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	2.65	2.12	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.45	2.91	2.91	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	11.42	1.35	1.23	1.72	0.00
Astrocyte - cerebellum, donor2	11580-120F5	12.67	2.05	1.37	1.20	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.60	0.42	0.63	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	47.76	4.18	2.09	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	40.93	6.15	2.43	2.10	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	31.03	3.88	2.54	1.19	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	42.66	9.06	6.31	4.36	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	45.60	9.27	6.39	5.01	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	48.59	11.95	7.28	5.35	0.68
Basophils, donor1	12241-129G9	10.20	6.80	2.09	2.88	0.78
Basophils, donor2	12242-129H1	36.80	11.91	5.05	2.89	0.00
Basophils, donor3	12243-129H2	18.23	7.64	4.26	2.35	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.47	0.65	1.08	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.93	1.88	0.63	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.81	1.66	1.04	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.59	1.38	0.92	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	13.50	1.26	1.26	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	43.80	5.87	2.58	1.65	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	54.27	5.59	4.19	1.86	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	19.19	4.16	2.88	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	31.00	12.96	5.64	5.64	0.00
CD14+ Monocytes, donor2	11305-117B9	37.49	12.25	8.54	4.64	0.37
CD14+ Monocytes, donor3	11381-118B4	27.44	10.54	5.93	3.73	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.91	3.68	1.42	1.98	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	30.33	1.90	1.90	1.90	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	36.49	6.90	1.31	3.29	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	20.96	6.22	2.31	4.63	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	17.50	7.24	1.21	1.81	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	19.19	9.24	2.84	3.79	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	16.24	4.02	2.01	2.18	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.08	5.52	2.76	3.31	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.13	6.94	4.46	1.24	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.99	4.31	3.33	1.96	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.60	6.23	2.49	1.42	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.32	5.66	3.26	2.61	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	16.86	2.58	1.64	1.64	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	7.39	2.64	3.17	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	14.42	3.33	1.11	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.68	5.65	2.38	1.34	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	13.77	7.38	2.00	3.39	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.28	6.25	2.71	1.46	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	16.47	5.95	2.06	5.49	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	13.57	5.88	3.17	2.26	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.09	4.36	2.18	2.18	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	17.48	5.38	3.77	1.61	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.92	7.50	3.14	3.84	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	19.36	7.57	2.52	3.37	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.33	4.78	2.02	2.02	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	10.22	6.34	2.82	2.47	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.85	3.51	3.51	1.75	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.16	4.71	2.96	2.27	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.01	5.20	2.60	2.23	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.12	6.47	2.80	1.08	1.08
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	4.09	2.05	2.05	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	9.97	3.94	2.09	2.78	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.30	3.94	2.32	1.39	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	20.05	4.36	4.14	1.09	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	19.40	5.08	3.93	2.54	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	17.76	2.82	3.25	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	26.16	6.38	3.27	2.80	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	22.01	4.89	2.62	0.52	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	31.66	5.35	2.45	2.01	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	15.57	6.63	2.81	1.79	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	18.66	5.49	3.73	1.98	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	18.53	6.32	4.21	2.32	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	22.37	8.14	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	26.93	8.28	3.11	3.11	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	29.32	6.93	3.20	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	29.48	8.04	1.07	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	23.87	4.91	1.40	4.91	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	25.88	6.27	1.57	3.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	9.23	5.27	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	27.94	17.26	7.40	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	21.04	19.59	12.33	4.35	1.45
CD19+ B Cells, donor3	11705-123B4	16.66	12.12	9.59	5.05	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	77.58	5.25	2.83	2.83	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	52.33	7.19	2.80	1.60	0.40
CD34+ Progenitors, donor1	11545-120B6	26.11	9.04	5.02	6.02	0.00
CD34+ Progenitors, donor2	11625-122B5	21.91	5.62	4.49	7.30	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.04	3.76	2.63	3.01	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	22.10	6.31	2.93	3.38	0.45
CD4+ T Cells, donor1	11225-116C1	50.70	11.43	9.64	1.07	0.71
CD4+ T Cells, donor2	11306-117C1	40.42	13.47	9.19	3.06	1.84
CD4+ T Cells, donor3	11382-118B5	36.29	7.01	5.49	2.13	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	37.01	3.32	2.81	1.02	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	33.69	3.59	3.37	1.12	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	36.22	4.02	2.30	1.44	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	31.29	2.84	1.90	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	26.69	2.11	2.81	3.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	27.17	3.61	2.60	1.01	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	23.72	3.73	1.69	1.02	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	19.34	3.06	1.45	0.81	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	39.90	3.59	4.03	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.83	4.54	3.14	1.75	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.92	3.52	3.96	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	36.68	2.11	3.37	2.53	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.57	3.12	2.49	1.66	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.72	2.00	3.01	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	39.43	1.63	3.54	2.18	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.34	3.22	4.82	3.22	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	1.79	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	44.13	4.26	4.08	1.11	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.98	2.38	2.60	1.08	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.64	3.99	2.52	1.68	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	23.26	5.56	5.06	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	29.03	1.30	2.17	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	42.71	2.61	4.79	2.18	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	42.06	6.93	2.47	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	24.93	1.85	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	5.58	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.02	3.05	7.20	1.94	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.07	2.94	4.66	1.23	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	52.36	7.70	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	44.41	7.88	5.73	1.79	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	41.55	5.54	2.77	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	41.91	17.35	6.55	6.55	0.65
CD8+ T Cells, donor2	11307-117C2	39.04	19.15	13.14	3.00	1.88
CD8+ T Cells, donor3	11383-118B6	38.38	15.65	7.32	4.29	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	9.41	3.67	2.06	1.38	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.43	2.64	3.12	0.96	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	11.22	2.46	1.64	1.64	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.71	3.90	2.40	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	6.96	1.92	1.92	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	10.23	2.73	2.73	0.23	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.30	1.52	1.74	0.65	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.11	0.79	3.42	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.90	2.11	2.58	0.94	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	12.68	2.11	2.11	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.07	1.74	1.74	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	17.85	2.66	1.33	1.33	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.51	2.19	1.75	0.88	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.39	2.28	1.37	0.91	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	1.49	2.24	0.75	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	2.16	1.08	1.80	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.93	2.59	2.59	1.15	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.96	1.89	1.41	1.65	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	13.63	1.58	1.27	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.07	1.54	1.54	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	18.59	3.85	1.28	1.28	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	14.92	3.06	1.15	1.15	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	12.61	0.79	1.58	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	15.13	1.51	0.00	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.07	0.00	0.80	0.80	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	17.49	2.10	0.70	0.70	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	17.03	2.00	3.01	2.00	4.01
Cardiac Myocyte, donor1	11525-119I4	36.55	3.66	3.66	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	11.36	2.47	1.98	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	26.52	1.37	2.10	0.95	0.11
Chondrocyte - de diff, donor1	11261-116G1	26.00	2.77	1.39	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.19	1.07	2.49	1.42	0.36
Chondrocyte - de diff, donor3	11410-118E6	17.86	3.30	2.16	0.91	0.11
Chondrocyte - re diff, donor2	11339-117F7	24.17	4.48	1.79	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	7.68	3.24	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	33.74	6.20	1.72	2.07	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	18.38	1.50	2.99	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	23.89	3.45	2.74	2.39	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.31	3.58	1.38	1.83	0.83
Corneal Epithelial Cells, donor1	11526-119I5	4.17	0.66	0.44	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.88	2.81	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.79	5.28	3.63	1.49	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.71	5.68	4.10	1.89	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.47	3.78	2.81	1.19	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	22.55	11.27	3.42	5.47	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	27.42	9.79	6.53	4.57	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	24.68	4.36	4.84	3.87	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	19.51	5.84	2.33	3.34	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	18.19	2.93	2.93	1.76	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	16.69	5.09	3.39	1.70	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	24.77	7.47	5.50	2.36	0.00
Endothelial Cells - Artery, donor1	11264-116G4	7.85	2.91	0.87	1.75	0.29
Endothelial Cells - Artery, donor2	11341-117F9	18.82	4.47	1.88	1.41	0.24
Endothelial Cells - Artery, donor3	11413-118E9	13.50	9.12	4.21	1.75	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.25	6.65	3.99	1.99	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.04	5.17	4.26	1.83	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	34.11	6.77	3.95	2.82	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	12.48	1.19	1.49	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	18.74	1.56	0.52	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	8.37	1.70	0.85	0.99	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	36.01	5.20	9.60	2.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	12.05	2.62	0.52	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	58.02	10.81	5.09	5.09	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	40.63	13.25	5.43	4.56	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	44.58	13.19	5.86	5.86	0.37
Endothelial Cells - Vein, donor1	11267-116G7	12.51	1.14	4.55	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	19.56	3.49	1.40	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	19.00	5.65	2.83	1.57	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	36.31	18.15	4.95	4.95	0.00
Eosinophils, donor3	12246-129H5	21.40	17.83	3.57	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	7.82	0.98	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	4.11	2.05	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	8.54	1.42	1.09	0.66	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.19	2.71	0.54	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	31.17	4.12	2.79	0.73	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.43	2.05	2.73	1.50	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.77	2.85	3.06	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	16.07	1.84	1.58	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	21.59	3.32	1.00	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	18.15	1.36	1.36	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	13.64	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.36	1.58	1.58	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	30.01	4.24	2.42	1.82	0.00
Fibroblast - Cardiac, donor5	11456-119A7	23.48	4.19	2.66	2.16	0.00
Fibroblast - Cardiac, donor6	11460-119B2	26.07	2.88	4.40	1.67	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	10.59	0.80	1.61	0.54	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.41	3.45	3.02	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	1.46	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	21.45	2.77	1.38	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	21.03	2.88	0.85	1.36	0.00
Fibroblast - Dermal, donor1	11269-116G9	21.13	2.82	2.82	2.11	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.98	4.72	1.89	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	20.43	2.78	2.90	0.97	0.12
Fibroblast - Dermal, donor4	11450-119A1	42.17	4.30	4.30	2.49	0.11
Fibroblast - Dermal, donor5	11454-119A5	43.61	4.54	4.88	2.79	0.17
Fibroblast - Dermal, donor6	11458-119A9	54.74	5.04	5.20	1.79	0.32
Fibroblast - Gingival, donor1	11237-116D4	28.94	5.00	2.71	0.62	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.39	6.03	3.67	1.83	0.26
Fibroblast - Gingival, donor2	11318-117D4	29.78	5.40	1.84	2.37	0.13
Fibroblast - Gingival, donor3	11394-118C8	24.27	4.64	2.71	1.16	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	4.16	4.16	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	16.74	3.52	2.11	1.23	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.79	6.55	5.92	4.21	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	37.59	4.33	3.25	2.16	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.94	11.29	2.82	5.65	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.30	6.87	4.53	1.90	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	37.63	5.59	4.77	1.23	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	49.69	8.45	7.57	1.43	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	19.37	2.93	0.88	1.17	0.00
Fibroblast - Lung, donor1	11270-116H1	9.52	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	0.00	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	14.56	3.59	1.69	0.63	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	0.83	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	1.40	4.20	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	0.28	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	23.95	3.25	3.65	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	51.60	7.76	2.52	2.13	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	56.12	6.37	2.43	3.34	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	49.26	7.34	5.81	1.84	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.95	6.87	5.72	1.91	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.01	3.24	2.16	1.08	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.70	4.87	1.62	1.39	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.51	4.31	3.09	0.77	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	13.41	3.05	1.22	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	0.67	0.67	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.81	0.79	3.56	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	23.42	1.59	4.37	2.58	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.01	3.37	1.07	1.07	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.07	3.74	1.38	1.38	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.95	3.61	2.11	2.41	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	30.98	3.13	5.72	1.84	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.55	3.29	2.02	1.77	0.00
Fibroblast - skin normal, donor1	11553-120C5	16.90	2.95	2.46	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	42.31	7.82	2.81	2.61	0.20
Fibroblast - skin normal, donor2	11561-120D4	31.55	3.52	4.22	3.01	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.31	3.93	4.23	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.61	3.23	2.82	1.16	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.33	2.39	2.91	1.37	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	20.36	1.64	1.31	1.64	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	27.59	4.79	3.62	1.28	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	26.31	4.05	2.36	1.86	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.25	2.82	2.20	0.94	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	66.48	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.12	3.49	6.97	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	18.72	2.60	2.08	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.78	1.30	3.38	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.95	3.32	3.07	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.09	6.12	2.30	2.30	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	29.99	2.55	2.55	4.47	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	47.64	8.56	1.43	4.56	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	35.02	2.76	0.00	1.65	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.99	1.60	0.68	1.37	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	28.73	3.76	1.98	4.16	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.87	2.11	0.79	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.29	2.28	0.65	2.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	37.59	7.08	2.65	3.10	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.14	2.69	1.13	2.26	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.67	3.32	1.35	1.97	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.52	2.42	1.61	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	36.05	2.35	1.73	1.73	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	36.41	3.32	0.55	2.63	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	24.80	3.05	1.63	2.03	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.70	1.83	1.14	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	39.49	2.49	1.49	1.49	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.29	3.72	0.87	1.97	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.48	1.77	0.59	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.06	3.18	1.11	2.54	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.45	2.46	1.34	1.34	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	29.84	3.02	1.21	2.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	39.87	4.07	1.02	1.87	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	64.82	6.47	1.86	3.01	1.60
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.51	2.81	0.94	1.35	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.06	2.39	1.02	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	36.29	4.20	1.33	1.55	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.33	3.74	2.50	2.08	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.41	2.45	0.61	1.23	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	32.18	2.89	1.03	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	37.12	3.11	1.04	1.73	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	27.52	3.00	1.33	2.00	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	28.88	1.32	1.32	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	37.51	2.71	1.11	2.21	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.91	4.70	1.62	1.95	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	24.70	3.53	0.64	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.29	3.51	1.14	1.99	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.78	2.37	1.42	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	30.10	3.65	1.52	2.13	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	28.02	3.76	1.46	2.93	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.49	1.54	0.44	1.76	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.65	1.96	0.84	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.29	3.70	2.04	1.76	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	28.34	3.48	0.53	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	27.69	3.83	1.84	2.14	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.52	4.53	1.81	0.91	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	18.98	3.52	0.54	2.71	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	24.15	3.87	2.21	2.21	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.00	3.07	2.19	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	4.96	1.98	5.95	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.57	4.09	0.79	1.32	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.99	3.63	2.02	1.41	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	41.94	6.35	0.51	2.80	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	57.73	2.99	2.59	3.78	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	44.99	4.62	3.24	2.62	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	62.60	5.73	2.05	2.45	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.16	2.82	0.94	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	21.19	1.98	1.13	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	35.97	4.61	0.92	3.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	14.85	7.42	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.85	1.93	1.93	2.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	1.60	3.21	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	17.39	3.48	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.67	2.93	2.60	2.60	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.36	3.71	2.88	1.65	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	29.99	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	30.76	5.31	1.12	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.42	1.96	2.61	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	29.36	0.84	0.00	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.03	1.59	1.27	1.59	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	30.91	2.72	1.70	2.04	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.93	2.86	1.15	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	23.97	2.66	0.89	0.89	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	3.39	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	33.97	3.31	2.49	0.83	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.91	5.06	2.53	0.69	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.06	1.15	1.15	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	25.10	0.98	1.30	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	2.01	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	32.36	1.54	1.93	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	40.40	4.11	2.40	1.03	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	2.48	4.97	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	29.73	1.89	0.94	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.99	1.21	0.60	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.12	2.54	1.02	2.54	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.31	2.79	1.20	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	35.52	1.48	0.49	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	41.32	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	26.84	1.75	0.58	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.74	1.32	1.32	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.97	1.70	0.00	3.39	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.70	4.18	1.19	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	3.40	0.49	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	5.41	1.25	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	15.74	0.00	3.37	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.10	2.54	1.90	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.53	1.25	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.76	1.51	2.09	0.35	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.50	1.69	2.03	0.84	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.74	2.28	1.59	1.14	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	9.51	1.64	2.40	0.77	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.25	1.93	2.58	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.99	1.72	1.72	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.09	1.49	1.37	0.50	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	1.20	2.23	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.81	0.96	2.56	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.67	2.80	2.24	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	1.73	2.16	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	5.29	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.81	0.35	2.12	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	0.73	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	22.90	2.27	2.62	0.70	0.17
Hepatocyte, donor1	11523-119I2	27.84	2.42	3.63	1.21	0.00
Hepatocyte, donor2	11603-120I1	23.70	4.31	4.31	2.15	0.00
Hepatocyte, donor3	11684-122I1	28.22	4.91	4.29	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	58.74	2.61	2.61	1.96	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.41	2.45	1.57	1.22	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.42	2.74	1.23	0.69	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	0.00	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	1.11	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	1.63	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.88	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	0.80	0.80	0.00	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.19	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	2.15	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	7.65	0.00	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	10.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.57	0.93	0.62	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	12.52	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	4.60	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	19.18	2.37	2.12	0.49	0.00
Keratinocyte - epidermal, donor2	11349-117G8	6.44	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	23.76	2.75	2.84	1.23	0.09
Keratinocyte - oral, donor1	11251-116E9	35.53	4.54	1.48	1.36	0.00
Keratocytes, donor1	11527-119I6	25.44	1.38	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	23.44	0.00	1.17	1.17	1.17
Keratocytes, donor3	11688-122I5	34.78	3.16	1.38	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	6.59	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	11.87	4.31	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	30.68	3.23	1.04	1.96	0.12
Lens Epithelial Cells, donor3	11690-122I7	21.59	3.94	3.13	2.32	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.45	2.61	1.78	1.30	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	7.26	1.67	2.51	1.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	22.67	3.62	2.68	2.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.98	2.15	1.08	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.82	2.52	1.58	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	7.44	2.05	1.83	1.19	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.18	1.23	2.05	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	1.01	0.51	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.01	1.97	2.39	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.63	1.98	1.19	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.93	2.91	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.85	0.93	0.74	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	1.39	1.39	3.48	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	10.02	1.67	1.43	1.67	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	8.65	2.20	0.96	1.37	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.94	2.46	1.23	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.48	0.94	0.94	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.25	2.20	2.01	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.87	3.29	1.32	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.74	1.17	2.05	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.73	1.00	1.74	1.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	2.91	2.42	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	14.00	1.89	1.62	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.05	2.57	2.12	1.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	1.04	2.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	21.36	3.14	2.51	1.68	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.17	1.65	1.20	1.20	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	1.38	1.38	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.91	1.51	1.51	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.06	1.48	0.95	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	1.94	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	1.65	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.44	1.73	0.87	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	20.73	2.96	1.11	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.33	3.46	0.99	1.73	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	8.80	2.06	1.24	0.55	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.01	2.89	1.29	1.29	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.26	4.56	2.43	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	12.88	2.52	1.68	1.26	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.27	2.49	1.78	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	0.97	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	0.62	0.78	0.62	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.10	2.51	1.43	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	2.61	0.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	1.18	0.71	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.71	3.47	2.48	1.11	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.17	1.02	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.07	1.79	1.19	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	2.27	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	2.30	0.00	2.30	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	8.91	2.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	1.27	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	2.11	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	1.87	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	1.03	1.03	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	9.05	0.68	0.68	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.47	1.74	0.00	0.58	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	11.70	0.90	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	11.25	1.08	0.54	1.35	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	9.76	2.05	1.03	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.35	2.47	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	8.66	0.00	2.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	11.72	2.04	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.41	1.33	1.33	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.47	1.51	1.51	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	0.61	2.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.87	1.67	1.04	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	12.89	1.96	2.80	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	2.06	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	1.45	1.16	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.05	2.09	0.60	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	9.41	2.21	2.21	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.25	1.77	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.80	1.84	1.84	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	3.45	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	12.28	1.15	1.15	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	1.13	1.13	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	0.00	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.49	1.36	0.90	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	1.44	1.44	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	2.24	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.01	1.11	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	0.43	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	0.00	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.00	2.00	0.67	1.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	2.41	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.27	2.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.87	1.37	0.34	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.00	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.59	1.11	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	1.06	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.01	2.00	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	7.27	0.73	0.00	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	5.37	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.41	1.97	0.49	1.48	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	1.88	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.05	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	0.90	1.35	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	10.69	1.34	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	11.73	0.78	0.78	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	6.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	1.56	1.56	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.19	0.88	0.44	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	8.39	0.56	1.12	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.95	0.44	0.88	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.57	0.00	2.31	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	13.67	1.52	1.52	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	2.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.73	0.80	1.19	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	0.00	1.82	0.00	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	2.08	1.38	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	9.12	1.90	1.52	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.33	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	8.47	1.81	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	10.14	3.49	1.27	0.95	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	13.86	2.67	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	14.37	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	10.28	0.00	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	17.68	0.71	2.83	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.81	2.84	0.00	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	1.25	0.83	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	11.75	0.78	0.00	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.53	0.84	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	11.62	0.93	1.39	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.70	2.01	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.90	2.14	3.21	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	1.62	0.40	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	2.75	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	1.78	2.67	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.98	2.28	1.14	1.71	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	0.77	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	1.64	1.64	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.92	2.23	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.38	2.08	0.78	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	1.99	0.66	2.65	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	25.75	5.24	0.91	2.05	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.27	5.14	2.20	1.28	0.18
Macrophage - monocyte derived, donor3	11389-118C3	22.02	4.85	3.80	2.88	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	17.52	2.66	2.66	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	29.47	1.74	1.74	0.79	0.16
Mallassez-derived cells, donor3	11930-125I4	27.80	1.81	3.20	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	36.47	3.69	2.09	0.80	0.10
Mammary Epithelial Cell, donor2	11350-117G9	26.06	2.03	4.05	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	11.47	2.24	0.75	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	26.44	6.78	6.10	2.03	0.00
Mast cell, donor1	11563-120D6	20.44	6.38	2.49	3.78	0.11
Mast cell, donor2	11565-120D8	19.61	5.05	0.89	1.78	0.59
Mast cell, donor3	11566-120D9	22.29	5.18	1.80	1.58	0.00
Mast cell, donor4	11567-120E1	14.71	2.84	0.71	2.13	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	16.63	4.32	1.77	2.66	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	16.34	3.50	1.75	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	17.90	5.16	1.38	1.84	0.23
Mast cell, expanded, donor8	11941-126A6	18.91	13.56	3.85	5.36	0.50
Melanocyte - dark, donor1	11502-119F8	27.96	5.77	5.17	1.69	0.10
Melanocyte - dark, donor2	11582-120F7	12.81	2.08	2.08	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	27.09	3.26	1.59	1.16	0.07
Melanocyte - light, donor1	11274-116H5	9.40	1.18	0.47	0.94	0.00
Melanocyte - light, donor2	11351-117H1	9.55	0.68	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	2.60	1.73	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	22.60	3.75	1.77	1.25	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	21.52	2.96	1.88	1.61	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	15.00	2.68	1.34	1.34	0.00
Meningeal Cells, donor1	11493-119E8	22.08	4.34	2.36	1.98	0.12
Meningeal Cells, donor2	11573-120E7	19.37	1.76	2.20	1.32	0.00
Meningeal Cells, donor3	11654-122E7	53.06	7.58	5.05	2.36	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.78	4.28	2.00	2.28	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.32	3.12	1.91	1.21	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	6.46	2.87	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	18.42	1.69	1.48	0.85	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.55	2.01	2.01	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.02	2.64	2.42	0.66	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	3.65	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.62	2.86	1.84	0.61	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.61	0.97	0.97	0.69	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.46	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.68	4.21	1.97	1.45	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.12	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	0.64	3.20	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.41	5.32	3.90	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	36.28	5.94	1.56	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	20.32	1.45	1.45	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	18.83	4.77	2.39	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	16.52	3.00	1.50	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	13.01	2.82	1.88	0.87	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	10.80	4.05	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	24.13	4.19	4.43	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.31	7.36	3.83	2.36	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	6.91	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.19	6.82	2.17	2.17	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.31	3.11	1.04	1.24	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.77	2.75	2.50	2.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	22.81	2.79	3.72	2.79	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	16.66	3.86	2.24	1.83	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	20.19	5.15	2.38	0.79	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	3.54	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.06	2.66	1.90	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	3.95	2.63	7.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.28	3.18	1.27	1.27	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	7.37	3.68	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	12.82	4.17	3.58	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	1.68	8.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	1.51	1.25	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.36	2.61	3.33	2.61	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.01	9.95	2.76	3.87	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.98	4.60	3.68	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.99	3.58	1.47	1.05	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	4.89	2.24	1.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.09	3.86	1.50	1.07	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	3.78	2.45	1.33	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.20	3.29	2.41	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	5.58	1.52	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	24.85	8.28	9.94	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.69	4.08	3.53	1.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	5.29	1.76	1.47	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	10.90	5.45	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	11.53	1.44	2.40	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	17.21	2.80	3.20	1.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	17.83	4.11	6.86	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.51	2.50	2.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.77	3.50	2.63	2.63	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	5.52	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	5.12	3.84	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.38	4.46	3.22	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	9.74	3.48	4.87	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	44.20	4.42	6.63	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.23	1.71	1.71	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	4.38	5.25	1.75	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	31.25	4.62	3.91	3.20	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.19	1.96	2.81	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.37	2.91	4.99	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	28.55	5.24	2.91	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	13.88	5.73	2.71	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	3.76	4.59	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	0.00	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	8.31	7.39	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	6.26	4.55	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.96	5.67	4.15	2.35	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	2.07	2.33	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.30	3.86	4.29	1.72	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	15.88	7.62	3.81	2.54	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.95	2.94	3.47	1.60	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.96	5.09	5.99	1.50	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.81	4.52	1.84	1.84	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	13.70	1.91	2.23	1.59	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.14	4.42	4.20	2.21	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	20.10	4.55	3.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	14.77	3.41	3.13	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.94	2.46	2.70	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.20	4.56	2.61	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.23	3.82	2.94	2.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.72	4.32	2.88	2.31	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	4.95	1.24	3.30	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	5.36	2.08	0.89	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	3.56	1.78	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	15.77	2.30	2.63	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	2.10	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.01	1.58	0.20	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	4.66	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.27	3.76	1.13	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.52	2.66	0.80	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.53	2.83	1.81	1.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.82	2.56	2.56	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	0.00	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	16.03	4.28	2.14	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	10.10	1.01	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	9.70	4.22	2.95	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	1.27	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	2.43	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51	3.02	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	6.52	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	9.50	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.81	1.29	1.72	0.86	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.20	1.57	1.05	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.02	4.00	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	6.68	3.76	2.92	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	26.05	7.23	4.18	1.52	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	71.81	4.79	4.79	7.98	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	4.08	2.72	1.36	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	80.86	18.38	11.03	11.03	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.44	5.44	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	4.65	0.93	1.86	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.00	3.24	2.97	1.35	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.76	3.99	2.52	1.68	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	22.27	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.92	1.49	2.48	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	11.64	3.25	1.62	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.99	2.95	1.36	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.04	5.23	2.29	2.45	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.79	3.10	2.55	1.64	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	2.12	2.12	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.01	4.20	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.00	9.85	3.28	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.34	3.42	1.63	0.49	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.81	5.64	3.70	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	2.81	2.11	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.27	4.14	1.38	1.38	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.28	4.18	2.25	1.93	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.28	4.48	3.79	2.76	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	98.61	27.81	20.23	15.17	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	23.17	6.68	3.12	1.78	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	3.39	2.54	2.12	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.73	5.70	0.95	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.44	2.15	2.15	2.58	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	9.03	27.08	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	18.66	2.67	1.00	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.78	6.31	2.71	2.71	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	5.95	1.59	1.59	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	9.29	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.62	0.00	2.65	2.27	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.15	3.58	1.30	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	4.36	0.44	1.74	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	29.85	4.98	3.17	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	6.17	3.53	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	3.99	1.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.89	2.48	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.55	4.98	1.15	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	13.01	2.72	1.51	2.42	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.08	5.53	4.64	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	8.81	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	25.55	10.22	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.19	1.22	1.83	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	4.09	1.26	0.94	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.84	4.54	0.91	2.12	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	1.58	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	7.94	10.20	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	10.12	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	31.06	5.22	4.47	1.86	0.25
Myoblast, donor2	11322-117D8	21.48	4.22	5.75	2.49	0.58
Myoblast, donor3	11398-118D3	30.61	5.38	4.04	4.20	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.65	6.13	2.19	1.75	0.00
Natural Killer Cells, donor1	11230-116C6	45.82	22.76	5.84	6.15	0.92
Natural Killer Cells, donor2	11311-117C6	44.03	16.59	9.95	5.43	0.90
Natural Killer Cells, donor3	11387-118C1	35.71	16.38	6.63	4.79	1.10
Neural stem cells, donor1	11275-116H6	75.13	11.25	3.27	5.08	0.73
Neural stem cells, donor2	11352-117H2	80.88	9.63	3.85	1.93	1.93
Neurons, donor1	11494-119E9	60.31	5.69	2.28	2.28	0.00
Neurons, donor2	11574-120E8	61.65	1.98	1.32	0.66	0.00
Neurons, donor3	11655-122E8	60.84	4.93	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	18.56	6.50	0.93	0.93	0.93
Neutrophils, donor2	11314-117C9	8.70	17.39	5.80	5.80	0.00
Neutrophils, donor3	11390-118C4	26.88	11.00	5.50	3.67	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	21.49	2.73	0.95	1.54	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	0.98	1.63	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	12.03	1.20	2.21	2.01	0.00
Olfactory epithelial cells, donor1	11933-125I7	12.80	2.48	1.10	0.83	0.00
Olfactory epithelial cells, donor2	11934-125I8	15.49	4.49	1.59	1.59	0.14
Olfactory epithelial cells, donor3	11935-125I9	13.96	2.95	2.95	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	25.03	5.06	2.05	1.36	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	6.02	4.21	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	16.59	2.34	1.06	1.28	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	9.14	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	7.45	1.24	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	12.70	1.37	0.59	1.37	0.00
Osteoblast, donor2	11354-117H4	40.03	7.02	7.02	3.51	0.00
Osteoblast, donor3	11426-118G4	23.99	4.80	1.78	1.24	0.00
Pancreatic stromal cells, donor1	11249-116E7	33.61	3.37	2.02	0.93	0.17
Pericytes, donor1	11491-119E6	5.56	0.22	0.67	0.89	0.00
Pericytes, donor2	11571-120E5	6.79	0.68	0.23	0.68	0.00
Pericytes, donor3	11652-122E5	11.39	1.83	2.64	0.81	0.00
Perineurial Cells, donor1	11499-119F5	27.58	2.26	2.15	0.79	0.11
Perineurial Cells, donor2	11579-120F4	25.21	2.85	1.56	0.83	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	48.77	11.79	4.78	4.14	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	26.69	9.79	4.41	4.16	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.58	8.67	4.40	2.85	0.26
Placental Epithelial Cells, donor1	11278-116H9	6.46	0.72	0.48	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	13.31	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.10	1.18	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.13	3.48	2.22	1.90	0.00
Preadipocyte - breast, donor1	11467-119B9	19.70	6.38	3.19	2.06	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.84	6.53	3.26	1.57	0.13
Preadipocyte - breast, donor2	11328-117E5	15.76	5.40	2.25	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	25.25	5.75	4.58	1.28	0.21
Preadipocyte - omental, donor2	11329-117E6	19.20	7.86	3.06	2.62	0.87
Preadipocyte - omental, donor3	11403-118D8	22.78	6.45	4.15	2.58	0.14
Preadipocyte - perirenal, donor1	11469-119C2	9.84	3.94	2.95	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	3.69	0.92	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	30.99	5.49	4.60	2.30	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	20.09	2.38	1.87	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	39.03	6.43	4.10	1.86	0.19
Preadipocyte - visceral, donor2	11357-117H7	28.99	4.14	7.36	2.76	0.92
Preadipocyte - visceral, donor3	11429-118G7	20.38	4.39	2.93	1.67	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	76.48	3.92	1.21	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	14.22	2.30	1.76	0.41	0.14
Prostate Epithelial Cells, donor3	11404-118D9	13.90	2.82	1.47	0.55	0.12
Prostate Stromal Cells, donor1	11254-116F3	21.07	2.85	2.05	0.34	0.23
Prostate Stromal Cells, donor2	11332-117E9	29.05	2.87	2.87	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	15.43	1.56	1.46	0.73	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.04	1.09	1.82	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.59	4.57	1.18	0.76	0.07
Renal Epithelial Cells, donor1	11517-119H5	9.64	0.51	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	8.54	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	40.12	3.39	1.69	1.16	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	0.00	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.38	2.83	1.21	1.89	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	36.19	7.33	5.11	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	1.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.46	1.54	1.54	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	15.67	1.88	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.44	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.57	2.68	2.68	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	2.53	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.76	2.12	1.16	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.89	3.63	1.81	3.37	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.37	1.42	0.57	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	8.23	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.09	2.26	1.25	1.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	29.27	5.35	1.47	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	2.68	0.89	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	2.20	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	15.66	4.64	5.22	1.74	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	20.15	1.43	2.99	1.04	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.29	3.57	2.38	1.59	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.08	3.23	1.90	1.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.23	2.98	3.35	1.24	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.02	1.98	0.82	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	17.10	4.85	1.62	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	12.73	2.05	1.92	0.68	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	15.13	2.27	1.51	1.51	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.46	3.94	1.08	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.34	1.86	1.86	0.86	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	15.24	3.22	1.61	1.29	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.48	3.10	3.10	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.57	2.68	3.82	1.72	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.84	4.01	3.35	1.21	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	22.55	5.26	2.25	0.56	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.99	1.99	3.45	1.86	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	14.31	4.87	2.24	0.97	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.23	3.82	2.86	1.34	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.20	1.92	4.06	1.60	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.54	1.40	1.96	1.12	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	17.09	3.25	2.91	0.34	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	13.31	2.92	2.73	2.01	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.35	3.56	1.96	1.10	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.10	4.43	2.55	2.01	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.32	1.89	3.77	1.89	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	14.68	2.58	2.18	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.86	4.91	1.87	0.70	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.03	1.45	3.53	1.04	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.69	5.09	3.76	0.66	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.92	4.80	3.55	1.25	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.55	2.96	2.29	1.75	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.50	4.43	2.72	2.21	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	18.51	6.56	3.08	1.16	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	12.38	3.09	2.24	0.69	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.11	3.98	3.15	2.33	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	17.24	4.93	3.12	1.97	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.59	1.53	3.24	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.09	3.70	1.92	0.89	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	14.93	4.00	1.60	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	15.07	2.49	0.41	1.24	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	13.33	1.90	0.95	1.43	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	15.52	4.23	1.81	2.82	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.85	2.07	1.32	1.22	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	12.58	2.79	2.45	1.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	12.39	4.84	2.72	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	8.93	2.20	1.84	0.86	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.05	4.66	2.91	2.18	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	10.34	2.43	2.43	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.34	1.51	0.90	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	11.99	1.58	0.68	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.08	1.80	1.20	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.70	0.71	1.30	0.35	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	9.18	1.92	1.28	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.02	1.20	2.40	0.60	0.60
Schwann Cells, donor1	11498-119F4	13.35	0.38	0.94	1.50	0.00
Schwann Cells, donor2	11578-120F3	27.22	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	20.37	2.41	1.53	1.75	0.00
Sebocyte, donor1	11220-116B5	13.69	2.19	1.64	0.00	0.00
Sebocyte, donor2	11301-117B5	10.57	1.84	2.30	0.46	0.00
Sebocyte, donor3	11378-118B1	5.77	1.44	1.44	0.41	0.00
Sertoli Cells, donor1	11255-116F4	31.48	1.66	4.97	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.18	1.94	0.70	0.62	0.00
Skeletal Muscle Cells, donor2	11358-117H8	2.89	0.72	0.72	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	9.20	2.51	1.67	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	25.92	4.87	3.46	1.89	0.16
Skeletal Muscle Cells, donor5	11455-119A6	23.78	3.57	3.57	2.68	0.00
Skeletal Muscle Cells, donor6	11459-119B1	35.86	4.77	4.92	1.69	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	39.31	3.53	2.27	0.76	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.83	3.28	1.28	1.85	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	38.79	5.85	3.67	1.79	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.47	3.37	2.19	1.18	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.87	1.51	0.83	0.96	0.14
Skin - palm, donor1	10286-104F7	80.58	2.69	10.74	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.53	1.15	0.72	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.18	0.82	2.45	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.42	3.12	1.95	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	32.94	1.67	1.11	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	16.18	3.80	1.97	1.55	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	41.65	4.44	2.33	0.85	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	18.14	3.52	1.87	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.65	2.78	3.09	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	20.68	1.11	1.33	1.33	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.40	1.18	1.18	2.35	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.65	1.99	1.77	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	9.45	1.97	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	2.32	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	26.02	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	18.76	3.06	2.53	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	1.99	1.99	1.99	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.63	2.69	2.30	1.41	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.00	3.58	1.63	1.30	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.60	4.43	3.25	1.18	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.65	3.56	1.99	1.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	8.62	0.98	0.98	0.98	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	4.87	3.65	2.13	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.47	1.26	1.52	0.25	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	11.44	0.95	0.95	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.17	2.65	1.77	1.47	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	21.95	3.01	2.15	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.39	3.04	2.83	0.94	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.90	2.32	1.70	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	6.47	3.23	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	21.22	1.20	1.20	2.09	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.00	0.00	2.39	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.29	2.20	1.41	1.41	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.28	4.43	2.31	0.91	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	22.30	4.55	4.55	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	2.42	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	65.44	6.62	6.62	2.65	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.03	2.13	1.46	1.33	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	22.04	2.63	2.38	0.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	10.65	1.01	0.76	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	28.50	2.26	3.32	1.66	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	19.50	1.50	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	69.78	6.46	14.21	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.93	5.58	2.33	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	14.64	3.03	1.51	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	1.88	3.76	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.96	0.59	0.88	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.81	8.91	6.33	3.83	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	3.27	2.80	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	16.98	3.31	2.01	1.01	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.28	2.04	1.53	0.76	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.43	1.69	0.94	1.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	41.22	5.31	4.05	2.24	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.33	4.52	3.10	1.51	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.90	3.91	1.71	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.55	2.87	1.77	1.99	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.09	0.29	0.59	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.05	2.14	1.75	1.55	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.34	2.38	1.85	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.60	2.23	1.86	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	3.95	2.52	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.43	1.99	2.56	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	17.72	2.76	1.18	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	11.94	2.79	1.52	1.78	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	11.18	2.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	9.20	1.67	0.84	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	6.88	0.92	1.38	0.92	0.00
Synoviocyte, donor1	11291-117A4	19.53	3.53	0.84	1.18	0.00
Synoviocyte, donor2	11368-117I9	13.75	3.35	1.84	0.17	0.00
Synoviocyte, donor3	11440-118H9	14.52	1.34	0.89	1.79	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	18.58	1.79	1.43	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.59	0.93	2.08	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	15.91	3.08	1.36	0.43	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.60	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	6.30	0.57	2.29	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	30.14	4.80	1.11	1.60	0.86
Urethra, donor2	10319-105A4	64.74	1.80	1.80	3.60	0.00
Urothelial Cells, donor1	11520-119H8	8.77	0.80	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	10.01	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	7.11	1.15	0.69	0.00	0.00
Urothelial cells, donor0	11216-116B1	24.30	3.79	2.45	2.01	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	23.13	5.34	2.67	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	5.72	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	7.53	4.11	2.74	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.87	8.26	1.38	2.07	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.08	6.39	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	4.16	2.08	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	21.11	1.84	2.75	2.75	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	15.52	4.56	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	27.51	3.08	1.97	1.36	0.49
Wilms' tumor cell line:HFWT	10597-108E3	38.72	1.76	1.76	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.92	5.31	1.40	1.12	0.00
achilles tendon, donor2	10292-104G4	31.00	10.33	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	12.75	2.55	2.55	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	52.94	4.41	2.55	3.02	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	29.80	4.87	1.90	1.90	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	45.44	5.71	5.71	4.08	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	24.45	5.62	3.65	1.69	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	16.07	9.31	4.44	5.29	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	16.60	9.53	3.54	7.89	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.12	3.08	4.85	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	24.91	6.13	2.45	3.68	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.57	6.60	4.27	2.33	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	50.05	8.28	6.44	3.13	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90	7.80	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.45	5.11	5.34	3.95	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	39.61	3.11	2.33	2.07	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.13	4.38	3.80	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	13.01	4.65	1.39	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	63.74	9.87	4.94	2.47	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	16.88	3.07	2.15	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.14	6.83	3.84	2.56	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	29.12	6.37	5.16	1.52	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	33.46	7.46	5.54	1.93	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.11	13.59	7.13	2.45	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	29.69	3.34	3.00	2.33	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	16.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.30	2.64	2.26	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.53	7.85	11.34	9.16	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	5.62	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	13.66	0.94	1.18	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	41.88	4.96	1.86	1.24	0.16
adipose, donor1	10184-103D4	54.54	2.35	0.59	2.35	0.00
adipose, donor2	10185-103D5	15.82	0.41	0.00	0.81	0.41
adipose, donor3	10186-103D6	34.31	0.54	0.27	1.63	0.00
adipose, donor4	10187-103D7	78.87	3.47	0.00	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	26.67	4.73	4.26	3.95	0.16
adrenal gland, adult, pool1	10081-102A9	0.00	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	14.14	1.87	0.53	0.80	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	22.87	6.79	4.29	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	18.78	2.09	1.85	1.16	0.70
amniotic membrane cells, donor2	12236-129G4	18.60	2.03	2.70	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	11.49	3.83	1.77	1.18	0.00
amygdala - adult, donor10196	10167-103B5	46.25	4.74	1.19	3.56	0.00
amygdala, adult, donor10252	10151-102I7	75.23	4.87	3.85	3.04	0.00
amygdala, newborn, donor10223	10360-105E9	34.86	2.26	1.61	1.29	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	18.59	1.78	1.15	0.51	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.43	3.97	1.99	2.21	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	54.78	2.34	1.00	1.67	0.33
aorta, adult, pool1	10052-101G7	20.20	5.69	1.57	1.37	0.00
appendix, adult	10189-103D9	25.62	6.21	2.33	1.94	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.83	4.47	2.75	1.38	0.69
artery, adult	10190-103E1	112.77	5.43	1.36	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	32.60	3.33	2.75	2.46	0.14
b cell line:RPMI1788	10427-106D4	27.96	5.65	2.83	1.78	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	24.42	1.11	1.66	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.66	3.87	1.98	1.39	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	6.36	0.33	0.33	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	6.71	2.80	2.24	1.12	0.00
bladder, adult, pool1	10011-101C2	50.84	5.43	1.52	2.39	0.22
blood, adult, pool1	10053-101G8	15.50	8.86	0.00	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	5.14	8.56	0.00	0.00
bone marrow, adult	10192-103E3	24.29	7.42	4.72	3.37	0.00
brain, adult, donor1	10084-102B3	23.58	3.08	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	44.10	4.68	1.11	2.67	0.11
brain, fetal, pool1	10085-102B4	42.74	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	25.77	4.29	3.30	3.30	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.95	3.37	1.00	1.62	0.50
breast, adult, donor1	10080-102A8	27.78	11.36	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.22	1.27	3.30	0.25	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.08	1.24	0.31	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	20.26	2.53	2.07	0.92	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.47	0.73	0.73	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	44.20	3.76	1.88	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.94	3.17	1.86	1.53	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	17.11	2.85	0.63	1.90	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	26.62	3.73	4.26	3.99	0.27
caudate nucleus - adult, donor10196	10177-103C6	28.78	6.91	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.05	5.02	2.18	1.67	0.50
caudate nucleus, adult, donor10258	10379-105H1	22.92	5.35	0.76	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	34.79	2.93	2.20	1.83	0.73
cerebellum - adult, donor10196	10173-103C2	81.57	5.83	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	76.65	4.70	1.28	3.42	0.00
cerebellum, adult, pool1	10083-102B2	20.01	2.07	1.03	2.41	0.00
cerebellum, newborn, donor10223	10357-105E6	53.97	2.49	4.98	3.32	1.66
cerebral meninges, adult	10188-103D8	56.73	5.29	1.51	3.78	0.00
cerebrospinal fluid, donor2	10294-104G6	87.71	1.46	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	10.35	0.72	0.58	0.72	0.00
cervical cancer cell line:ME-180	10553-107I4	19.39	4.64	1.33	0.17	0.00
cervix, adult, pool1	10013-101C4	31.29	4.30	1.47	2.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	20.90	3.20	1.81	1.11	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	6.53	1.31	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	20.01	1.49	0.12	0.62	0.12
choriocarcinoma cell line:SCH	10785-110H2	22.06	2.83	1.11	0.99	2.46
choriocarcinoma cell line:T3M-3	10618-108G6	28.22	3.08	3.08	0.24	2.13
chorionic membrane cells, donor1	12238-129G6	13.11	3.42	2.56	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	29.03	4.37	2.98	0.70	0.40
chorionic membrane cells, donor3	12240-129G8	20.33	1.65	0.55	1.10	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	34.33	1.01	2.02	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.56	6.15	2.11	1.73	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	25.34	3.17	3.17	2.32	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	16.44	0.51	1.03	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.11	2.42	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	15.68	1.22	0.81	0.20	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	28.86	1.18	1.18	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.26	9.38	7.30	7.30	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	8.91	0.91	0.69	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	9.54	0.35	0.69	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	84.38	4.94	2.20	1.28	1.65
colon carcinoma cell line:COLO-320	10420-106C6	84.00	9.88	0.76	0.76	1.14
colon, adult, donor1	10082-102B1	24.99	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	34.43	3.17	1.41	0.59	0.00
colon, fetal, donor1	10070-101I7	21.01	4.33	0.62	3.09	0.00
common myeloid progenitor CMP, donor1	12130-128D6	82.50	32.08	13.75	22.92	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.67	4.25	1.70	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.58	4.53	3.32	1.06	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	24.54	5.08	3.53	1.83	0.28
corpus callosum, adult, pool1	10042-101F6	40.02	3.98	1.33	2.65	0.00
cruciate ligament, donor2	10295-104G7	38.09	4.05	4.05	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	67.42	10.43	3.21	1.61	0.00
diencephalon, adult	10193-103E4	25.44	3.36	1.20	3.12	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.81	3.90	2.07	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.31	2.56	2.05	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.37	3.13	1.44	0.72	0.00
ductus deferens, adult	10196-103E7	29.40	3.99	1.50	4.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	25.75	7.36	2.94	2.94	0.00
dura mater, adult, donor1	10041-101F5	35.02	7.27	2.81	4.29	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.54	3.11	1.33	0.89	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	30.23	3.01	1.00	0.72	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	28.36	3.70	3.08	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	16.65	3.63	3.33	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.01	5.25	6.17	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	19.70	5.25	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	11.73	0.67	0.67	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	26.46	3.81	2.54	1.81	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.65	3.38	2.57	1.93	0.64
epidermoid carcinoma cell line:A431	10426-106D3	17.45	6.11	2.33	0.89	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	28.82	3.74	1.98	0.33	0.11
epididymis, adult	10197-103E8	19.05	3.77	0.63	2.51	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.53	1.77	1.60	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.73	0.79	2.36	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.69	3.67	3.28	1.31	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.88	2.26	3.94	0.69	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.71	2.58	3.02	0.45	0.78
esophagus, adult, pool1	10015-101C6	36.31	4.88	3.08	1.17	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	50.22	4.26	2.88	2.76	0.75
eye - muscle inferior rectus, donor1	10272-104E2	62.78	4.83	0.00	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	98.90	10.52	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	52.09	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	60.76	5.73	1.15	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	58.30	2.91	0.00	7.29	0.00
eye, fetal, donor1	10054-101G9	28.98	4.32	0.76	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	25.90	4.10	3.97	1.92	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	30.63	10.21	5.70	1.90	0.00
frontal lobe, adult, pool1	10040-101F4	51.42	5.16	1.22	2.91	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	47.14	6.91	4.80	4.50	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.76	1.37	1.46	0.46	0.09
gall bladder, adult	10198-103E9	23.42	3.38	1.21	1.69	0.00
gamma delta positive T cells, donor1	11937-126A2	34.36	4.29	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	33.99	8.59	3.73	3.73	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	14.36	5.91	2.53	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.89	2.71	1.16	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	17.54	1.80	1.64	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	34.78	3.66	2.75	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.54	1.60	1.14	1.37	0.23
giant cell carcinoma cell line:LU65	10487-107B1	18.01	0.11	0.23	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	15.40	2.24	1.54	0.84	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	20.45	2.49	4.99	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	20.48	6.65	2.64	2.01	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	21.49	5.90	3.23	1.69	0.00
glioblastoma cell line:T98G	10485-107A8	22.30	4.30	1.88	1.55	0.00
glioma cell line:GI-1	10413-106B8	29.58	2.93	2.05	2.64	0.29
globus pallidus - adult, donor10196	10175-103C4	34.99	8.02	3.64	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	69.57	6.10	4.64	2.93	0.00
globus pallidus, adult, donor10258	10367-105F7	42.45	6.85	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	31.44	3.20	1.07	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	88.10	56.28	9.79	17.13	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.48	3.20	3.20	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	34.43	0.46	1.38	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	27.44	2.74	0.46	1.37	1.83
hIPS +CCl2, biol_rep3	14385-156C2	32.85	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	25.87	0.00	4.31	0.00	0.00
hIPS, biol_rep2	14381-156B7	18.52	1.37	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	28.69	2.21	2.21	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	18.39	4.60	2.59	2.01	0.29
heart - mitral valve, adult	10205-103F7	31.39	3.29	2.69	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	42.62	4.45	0.78	2.61	0.26
heart - tricuspid valve, adult	10207-103F9	54.95	23.31	9.16	5.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	25.10	4.49	2.04	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	36.20	4.26	2.13	2.13	0.00
heart, adult, pool1	10016-101C7	38.41	7.13	2.53	3.68	0.23
heart, fetal, pool1	10046-101G1	67.05	4.72	1.23	1.54	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.68	3.70	2.78	1.85	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	89.19	2.38	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	52.93	4.31	5.52	1.99	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	56.80	4.98	6.31	1.82	2.91
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	58.51	4.75	4.65	2.02	1.92
hepatoma cell line:Li-7	10484-107A7	17.46	0.89	0.89	0.44	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	44.22	7.44	4.72	1.61	0.30
hippocampus - adult, donor10196	10169-103B7	43.53	4.73	0.95	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	67.35	5.10	3.67	2.65	0.20
hippocampus, adult, donor10258	10374-105G5	29.88	0.50	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	34.54	2.11	2.82	2.47	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	36.62	4.88	4.27	4.27	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.02	3.14	2.16	2.95	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	31.74	4.82	2.54	4.06	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	0.56	1.13	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	30.99	2.32	0.77	2.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.89	0.76	0.38	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	37.08	1.46	1.46	1.17	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	36.41	1.08	0.22	1.29	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	27.11	1.67	0.83	1.67	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	43.10	1.42	0.24	2.37	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	30.70	3.38	1.93	2.57	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.70	1.35	0.00	0.00	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.70	4.07	1.56	3.13	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.53	3.93	0.00	2.46	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	50.62	5.24	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	33.22	3.05	0.38	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	31.40	0.87	0.44	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	27.49	1.00	0.00	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	33.53	0.57	0.00	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	27.28	0.45	0.91	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	26.00	0.94	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	26.62	1.96	0.98	1.14	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.64	0.87	0.29	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.61	0.30	0.60	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	40.27	3.88	2.03	2.59	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	31.10	6.85	2.57	2.57	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	55.94	4.90	0.82	2.86	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	23.24	2.46	0.35	0.70	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	25.02	0.63	0.95	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	26.63	2.42	0.91	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	0.00	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	31.88	0.66	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	25.14	0.51	0.26	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.84	1.28	0.77	1.79	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	30.29	0.76	3.03	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	30.58	1.01	0.67	2.35	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.33	5.55	1.21	1.93	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	36.99	4.46	1.78	2.23	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	36.59	1.95	3.41	2.93	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	24.76	0.92	0.61	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	201.70	0.00	6.51	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.37	1.32	0.00	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	39.95	0.55	1.64	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	29.67	0.36	0.36	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.03	0.36	0.00	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	3.58	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	56.47	1.35	0.41	0.41	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	19.40	2.16	0.54	1.62	0.81
immature langerhans cells, donor1	11904-125F5	12.83	7.75	7.02	5.81	0.48
immature langerhans cells, donor2	11905-125F6	14.26	3.96	3.96	3.96	0.79
insula, adult, pool1	10039-101F3	43.82	4.26	1.14	2.56	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	12.36	1.95	1.95	0.33	0.33
kidney, adult, pool1	10017-101C8	19.62	3.20	1.90	1.20	0.10
kidney, fetal, pool1	10045-101F9	20.02	2.33	0.99	1.63	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.62	1.85	2.27	0.71	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	10.92	0.55	0.55	0.28	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	15.60	2.57	0.92	0.37	0.18
left atrium, adult, donor1	10079-102A7	29.42	2.18	2.18	3.81	0.00
left ventricle, adult, donor1	10078-102A6	34.38	3.03	1.01	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	33.11	4.92	1.92	2.19	0.00
leiomyoma cell line:10964C	10569-108B2	17.96	4.31	1.44	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	14.13	2.17	2.72	0.54	0.54
leiomyoma cell line:15425	10571-108B4	22.34	2.19	2.19	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	13.59	1.05	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	26.21	4.13	2.48	1.77	0.12
liposarcoma cell line:KMLS-1	10782-110G8	15.46	3.91	1.87	1.09	0.16
liposarcoma cell line:SW 872	10726-110A6	28.39	3.53	1.83	1.46	0.37
liver, adult, pool1	10018-101C9	38.89	3.57	2.92	0.49	0.16
liver, fetal, pool1	10086-102B5	12.23	6.58	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	58.62	8.17	2.92	3.65	0.44
locus coeruleus, adult, donor10252	10165-103B3	47.61	6.64	2.95	2.21	0.18
locus coeruleus, adult, donor10258	10375-105G6	16.08	2.26	1.13	2.26	0.00
locus coeruleus, newborn, donor10223	10362-105F2	36.17	5.47	1.68	2.52	1.26
lung adenocarcinoma cell line:A549	10499-107C4	12.18	0.83	0.55	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	4.83	3.45	3.45	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	18.85	1.19	1.85	0.92	0.00
lung, adult, pool1	10019-101D1	34.02	5.55	1.65	1.06	0.24
lung, fetal, donor1	10068-101I5	46.81	3.71	3.14	2.85	0.57
lung, right lower lobe, adult, donor1	10075-102A3	19.70	8.71	2.75	3.67	0.00
lymph node, adult, donor1	10077-102A5	15.15	6.15	1.89	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	16.44	2.63	1.32	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	28.53	6.49	3.47	2.41	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	8.49	6.80	0.00	0.00
mature adipocyte, donor1	12231-129F8	27.08	3.11	1.33	1.33	0.44
mature adipocyte, donor2	12232-129F9	30.51	5.40	2.70	1.87	0.21
mature adipocyte, donor3	12233-129G1	32.71	3.56	1.90	0.47	0.24
mature adipocyte, donor4	12234-129G2	26.32	1.84	1.84	1.05	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.45	2.62	1.67	2.14	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	3.38	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	65.10	6.99	1.84	3.13	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	38.44	1.59	0.95	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	80.61	3.41	0.85	1.71	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	50.79	4.56	3.04	3.21	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	84.25	6.37	3.40	1.91	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	23.12	1.93	1.93	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	43.06	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	42.00	1.79	1.44	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	25.31	4.54	0.00	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	42.42	7.43	1.70	3.56	0.46
medulla oblongata, adult, pool1	10038-101F2	33.47	5.47	2.04	2.53	0.00
medulla oblongata, newborn, donor10223	10361-105F1	26.73	6.60	1.74	2.43	1.04
medulloblastoma cell line:D283 Med	10838-111E1	61.11	5.54	2.66	3.54	0.89
medulloblastoma cell line:ONS-76	10759-110E3	24.58	5.26	1.83	2.08	0.24
melanoma cell line:COLO 679	10514-107E1	12.79	2.16	1.87	0.72	0.00
melanoma cell line:G-361	10465-106H6	21.17	1.63	0.27	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	13.21	1.99	0.72	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	53.75	0.00	1.76	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	60.14	3.89	3.89	4.15	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	23.17	3.38	3.99	2.61	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	16.18	1.82	3.09	0.73	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.81	2.07	4.97	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.84	2.67	1.55	1.12	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.79	2.70	3.27	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.80	2.08	2.08	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.07	1.89	2.23	0.34	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.37	2.07	1.61	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.72	2.92	1.46	1.72	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	20.12	3.92	2.97	1.89	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.76	3.27	2.85	0.85	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.20	2.96	1.65	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.40	3.87	2.63	2.35	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.44	4.89	2.79	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.54	2.25	2.65	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.94	3.59	1.80	2.16	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.93	1.55	1.55	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.86	2.74	2.28	1.37	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.98	3.36	5.45	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	16.14	2.54	2.54	1.94	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.52	2.80	3.33	1.58	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.83	1.47	2.58	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	2.29	1.72	1.72	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.47	5.89	2.11	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	3.65	2.28	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.05	3.33	2.81	1.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.40	3.66	1.57	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	11.40	2.46	1.23	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.30	3.53	1.88	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	2.37	2.71	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	9.43	1.18	2.75	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.22	1.85	1.39	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.00	2.88	4.33	0.58	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.62	2.68	2.68	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.58	3.12	2.40	1.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	2.93	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.76	1.34	2.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	0.41	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	12.46	0.86	4.30	2.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.07	3.57	2.27	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	7.27	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.86	1.60	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	1.64	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	17.10	1.94	2.33	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	0.99	3.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	15.42	2.96	1.78	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.20	5.07	3.80	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.42	2.41	1.72	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	1.22	2.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	5.56	2.38	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	1.18	1.77	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	1.25	1.56	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	1.38	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.39	2.97	2.47	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	8.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.90	1.91	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.88	1.21	1.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	9.71	1.82	2.43	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	2.47	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.13	1.19	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.33	1.30	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	3.06	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	5.42	1.55	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	25.04	3.07	1.65	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	8.80	2.09	0.93	1.39	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.14	2.36	0.92	1.03	0.21
mesothelioma cell line:Mero-25	10850-111F4	12.94	0.68	0.91	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	24.20	4.16	5.13	1.71	0.24
mesothelioma cell line:Mero-48a	10852-111F6	17.94	2.21	2.66	1.33	0.00
mesothelioma cell line:Mero-82	10853-111F7	15.77	2.89	2.37	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	28.60	5.11	3.74	0.68	0.51
mesothelioma cell line:Mero-84	10855-111F9	16.68	4.04	2.27	1.26	0.25
mesothelioma cell line:Mero-95	10856-111G1	15.74	3.73	1.86	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	26.17	3.81	2.82	1.16	0.17
mesothelioma cell line:NCI-H226	10846-111E9	36.56	6.70	4.71	1.09	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	15.54	1.20	2.22	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	11.96	3.56	2.29	3.31	1.02
mesothelioma cell line:No36	10857-111G2	11.74	2.61	1.30	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	21.41	2.98	2.71	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	24.76	3.45	1.54	3.07	0.38
migratory langerhans cells, donor2	11902-125F3	16.49	2.56	1.34	1.71	0.00
migratory langerhans cells, donor3	11903-125F4	21.90	3.59	1.08	2.51	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	34.61	6.86	2.94	2.29	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.74	0.85	1.70	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	20.27	5.07	1.61	0.92	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	14.08	3.43	1.14	2.09	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	34.00	5.17	2.77	1.11	0.18
myeloma cell line:PCM6	10474-106I6	15.81	3.36	0.79	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.87	3.04	2.03	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.71	4.51	2.16	0.98	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.05	1.56	0.56	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.40	1.76	0.88	0.51	0.00
nasal epithelial cells, donor2	12227-129F4	23.18	1.66	1.66	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	57.52	1.38	0.23	1.15	0.23
neuroblastoma cell line:NB-1	10539-107G8	40.22	3.93	3.18	2.43	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	35.64	2.32	1.69	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	45.10	2.42	0.93	1.12	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.25	0.95	0.95	0.47	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	9.98	3.17	0.95	2.06	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	16.70	3.62	1.81	1.21	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	48.95	8.26	3.81	4.45	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	18.37	6.12	3.46	1.60	0.00
neutrophil PMN, donor1	12133-128D9	29.75	29.75	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	26.56	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	78.98	5.58	2.20	0.68	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	19.21	2.40	2.40	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	2.89	1.28	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	17.61	2.89	1.58	2.63	0.00
nucleus accumbens, adult, pool1	10037-101F1	46.96	4.50	1.69	2.81	0.00
occipital cortex - adult, donor10196	10172-103C1	39.15	8.24	2.06	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	86.14	5.37	2.95	1.88	0.27
occipital cortex, newborn, donor10223	10355-105E4	48.77	4.00	1.09	1.09	2.18
occipital lobe, adult, donor1	10076-102A4	27.81	4.99	0.79	4.72	0.00
occipital lobe, fetal, donor1	10073-102A1	69.94	2.15	1.72	3.43	0.43
occipital pole, adult, pool1	10036-101E9	29.96	2.37	0.95	2.68	0.08
olfactory region, adult	10195-103E6	43.18	4.78	1.91	2.10	0.19
optic nerve, donor1	10277-104E7	56.03	8.00	2.00	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.17	2.28	1.14	0.34	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.54	3.43	1.37	1.51	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.49	7.96	4.91	1.52	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	23.79	3.47	2.19	1.27	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	24.11	8.53	2.94	2.35	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	26.16	6.54	7.47	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	13.78	6.15	1.06	1.48	1.06
ovary, adult, pool1	10020-101D2	28.39	3.49	1.57	1.92	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.13	3.12	1.83	1.28	0.37
pancreas, adult, donor1	10049-101G4	15.05	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	14.54	4.47	3.35	1.68	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	10.90	2.73	0.85	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	15.23	2.15	0.99	0.66	0.50
paracentral gyrus, adult, pool1	10035-101E8	45.76	4.30	1.01	3.11	0.00
parietal cortex, adult, donor10258	10373-105G4	30.09	1.47	2.20	3.67	0.00
parietal lobe - adult, donor10196	10171-103B9	33.86	0.94	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	80.38	3.99	2.57	4.28	0.29
parietal lobe, adult, pool1	10034-101E7	46.35	5.20	1.32	1.94	0.09
parietal lobe, fetal, donor1	10072-101I9	75.65	1.94	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	48.98	3.36	1.12	0.75	1.12
parotid gland, adult	10199-103F1	27.75	1.23	1.23	1.85	0.00
penis, adult	10200-103F2	44.04	3.22	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	14.13	2.05	1.30	1.30	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	17.19	6.26	2.33	1.02	0.15
pineal gland - adult, donor10196	10179-103C8	59.34	2.58	1.29	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	64.55	2.96	1.78	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	39.51	2.51	0.63	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	32.38	8.09	5.06	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	60.98	6.78	3.13	3.65	0.00
pituitary gland, adult, donor10258	10378-105G9	20.43	3.40	3.40	1.70	0.00
placenta, adult, pool1	10021-101D3	20.86	3.87	1.08	1.83	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	29.53	4.63	2.25	2.25	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	11.52	2.49	1.40	0.78	0.00
pons, adult, pool1	10033-101E6	41.74	5.08	2.24	2.50	0.00
postcentral gyrus, adult, pool1	10032-101E5	32.78	3.23	0.61	2.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	50.19	16.73	12.55	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	5.51	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	30.01	1.02	1.75	0.58	0.58
prostate cancer cell line:PC-3	10439-106E7	21.42	4.72	0.73	1.82	0.54
prostate, adult, pool1	10022-101D4	30.65	3.08	0.82	1.45	0.00
putamen, adult, donor10196	10176-103C5	51.70	6.37	3.07	4.01	0.00
putamen, adult, donor10252	10152-102I8	41.18	7.84	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	1.09	5.46	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	22.23	6.77	1.21	3.14	0.24
putamen, newborn, donor10223	10365-105F5	47.98	3.00	2.25	1.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	30.55	2.62	1.45	1.16	0.87
rectum, fetal, donor1	10067-101I4	22.26	2.78	0.00	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.54	2.76	1.27	1.27	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.77	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	29.32	3.48	0.99	1.59	0.10
retinoblastoma cell line:Y79	10475-106I7	65.21	1.56	0.52	1.04	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.20	3.32	2.95	2.09	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.87	1.97	0.56	2.53	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	4.55	4.55	3.79	0.00
salivary acinar cells, donor1	11771-123I7	21.69	4.53	2.10	0.65	0.00
salivary acinar cells, donor2	11772-123I8	22.86	3.30	1.65	1.24	0.14
salivary acinar cells, donor3	11773-123I9	29.13	10.59	3.97	1.99	0.66
salivary gland, adult, pool1	10093-102C3	12.58	1.72	0.57	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	33.47	4.30	3.12	1.60	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.74	3.76	3.29	1.41	0.35
seminal vesicle, adult	10201-103F3	24.87	4.23	1.59	2.65	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	2.67	2.67	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	18.12	2.77	3.02	1.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	30.11	9.03	6.02	4.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.18	0.94	0.13	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	24.32	2.76	1.11	0.88	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	17.29	0.90	1.55	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	229.12	2.13	4.26	2.13	0.00
skeletal muscle, adult, pool1	10023-101D5	147.16	7.80	3.84	1.68	0.48
skeletal muscle, fetal, donor1	10066-101I3	23.12	2.01	2.01	4.02	0.00
skin, adult, donor1	10074-102A2	20.36	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	18.31	1.89	1.26	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.68	3.34	0.67	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.18	3.78	0.63	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	34.69	4.24	2.31	0.58	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	29.67	5.44	2.80	1.98	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	126.27	4.50	2.25	1.77	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	8.28	1.09	0.87	0.44	0.44
small intestine, adult, pool1	10024-101D6	41.45	3.94	1.79	0.96	0.12
small intestine, fetal, donor1	10064-101I1	19.41	3.93	2.21	0.98	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	13.34	1.03	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	39.80	4.65	2.07	2.58	0.00
somatostatinoma cell line:QGP-1	10781-110G7	14.47	1.61	0.54	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	51.16	11.47	2.06	6.65	0.23
spinal cord, adult, donor10252	10159-103A6	43.76	11.83	3.94	2.37	0.39
spinal cord, adult, donor10258	10369-105F9	14.53	2.08	2.77	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	31.10	1.83	1.22	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	56.02	4.59	2.76	2.30	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.66	4.78	4.33	1.34	0.00
spleen, adult, pool1	10025-101D7	25.99	4.85	2.86	1.32	0.33
spleen, fetal, pool1	10044-101F8	21.85	3.97	2.07	1.83	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	14.08	3.52	1.24	0.83	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	13.48	1.52	0.95	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	20.97	5.59	5.59	2.10	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.28	4.69	1.17	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	12.61	0.56	0.68	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	0.42	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.12	1.69	2.96	0.85	0.00
stomach, fetal, donor1	10062-101H8	23.50	6.41	3.20	1.07	0.00
submaxillary gland, adult	10202-103F4	26.77	1.14	0.57	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	46.32	5.61	2.49	2.49	0.21
substantia nigra, adult, donor10258	10371-105G2	26.90	1.03	2.07	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	30.38	4.24	3.53	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	41.04	3.21	2.75	1.15	0.23
temporal lobe, adult, pool1	10031-101E4	38.49	3.22	1.02	2.03	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	64.82	2.85	0.71	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	50.11	0.00	1.76	0.88	0.44
tenocyte, donor1	11763-123H8	26.53	2.09	2.79	0.35	0.00
tenocyte, donor2	11765-123I1	16.79	2.67	1.91	1.91	0.00
tenocyte, donor3	11768-123I4	21.50	4.82	2.97	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	39.60	4.25	1.53	1.70	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	26.51	4.16	1.39	2.93	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.50	2.17	1.39	2.32	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	27.17	9.77	2.79	2.29	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.77	2.65	2.65	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	33.59	5.02	3.27	2.62	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	57.65	4.89	2.93	1.95	0.00
testis, adult, pool1	10026-101D8	63.35	2.68	1.93	1.29	1.50
testis, adult, pool2	10096-102C6	80.74	4.06	3.16	3.16	2.71
thalamus - adult, donor10196	10168-103B6	41.95	2.21	2.21	2.21	0.00
thalamus, adult, donor10252	10154-103A1	56.42	7.81	1.56	2.97	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	36.95	1.54	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.12	1.65	0.99	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	27.62	3.45	3.45	1.15	0.58
throat, adult	10209-103G2	44.19	3.50	2.25	0.50	0.25
throat, fetal, donor1	10061-101H7	34.13	4.57	1.52	2.74	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	28.82	3.58	1.59	0.79	0.20
thymus, adult, pool1	10027-101D9	44.94	4.08	1.89	2.58	0.60
thymus, fetal, pool1	10043-101F7	47.69	4.78	1.66	1.77	1.77
thyroid carcinoma cell line:KHM-5M	10776-110G2	19.41	3.59	3.86	1.46	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	15.79	2.65	1.68	0.84	0.14
thyroid, adult, pool1	10028-101E1	33.03	7.00	2.33	2.24	0.28
thyroid, fetal, donor1	10060-101H6	26.37	5.80	2.90	2.64	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	55.43	12.32	3.08	3.08	0.00
tongue, adult	10203-103F5	46.52	4.65	3.26	1.63	0.00
tongue, fetal, donor1	10059-101H5	80.79	5.52	1.97	1.18	0.00
tonsil, adult, pool1	10047-101G2	23.54	4.81	2.70	1.70	0.10
trachea, adult, pool1	10029-101E2	32.47	4.34	2.13	2.04	0.25
trachea, fetal, donor1	10058-101H4	25.77	3.85	0.77	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	29.05	4.96	3.54	3.54	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	23.81	2.63	1.22	1.22	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.01	5.33	4.23	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	36.15	3.81	1.90	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.46	1.86	1.78	0.68	0.00
umbilical cord, fetal, donor1	10057-101H3	14.61	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	33.96	2.90	1.02	3.07	0.00
uterus, fetal, donor1	10055-101H1	29.18	2.05	1.54	2.05	0.00
vagina, adult	10204-103F6	49.76	7.75	0.65	3.23	0.65
vein, adult	10191-103E2	21.70	5.04	2.19	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.02	2.94	1.60	0.53	0.00